Summary
The purpose of this study was to investigate the influence of two different concentrations of zeolite A on calcium homeostasis of ruminants. Seventeen growing goats were divided into three groups. While the control group received no addition, zeolite A at either 1.2 g/kg or 1.6 g/kg body weight, respectively, was added to the two treatment groups. Blood and urine samples were drawn continually and bone mineral density was measured weekly by peripheral quantitative computed tomography. After three weeks, the animals were slaughtered and samples were taken from the rumen, duodenum and kidneys. Plasma calcium concentrations were not altered. Plasma concentrations of phosphate, magnesium and 1,25-dihydroxycholecalciferol as well as renal excretion of phosphate were significantly lower in the treatment groups compared to the control group. Although bone resorption was increased in both treatment groups no alterations in bone structure were detected. Determination of gastrointestinal absorption of calcium by Ussing chamber technique and quantification of RNA and protein expression of genes known to be involved in active calcium absorption did not reveal any stimulating effect of zeolite. However, the effects on 1,25-dihydroxycholecalciferol, bone metabolism and serum concentrations of phosphate and magnesium shown in the present study should be considered whenever rations with zeolite are designed for ruminants. 
Abstract
The purpose of this study was to investigate the influence of two different concentrations of zeolite A on calcium homeostasis. Seventeen growing goats were divided into three groups. While the control group (5 animals) received no supplementation, two treatment groups were supplemented with zeolite A at either 1.2 g/kg (6 animals) or 1.6 g/kg body weight (6 animals), respectively. Blood and urine samples were drawn continually and bone mineral density was measured weekly by peripheral quantitative computed tomography. After three weeks, the animals were slaughtered and samples were taken from the rumen, duodenum and kidneys. Plasma concentrations of phosphate (P < 0.001), magnesium (P < 0.001) and 1,25-dihydroxycholecalciferol (P < 0.01) as well as renal excretion of phosphate (P < 0.05) were significantly lower in the treatment groups compared to the control group. Although bone resorption was increased in both treatment groups (P < 0.05) no alterations in bone structure were detected. Determination of gastrointestinal absorption of calcium by Ussing chamber technique and quantification of RNA and protein expression of genes known to be involved in active calcium absorption did not reveal any stimulating effect of zeolite. Plasma calcium concentrations were not altered, probably because of the sufficient dietary calcium supply. However, the effects on 1,25-dihydroxycholecalciferol, bone metabolism and serum concentrations of phosphate and magnesium shown in the present study and thus potential negative long-term effects on the animals should be considered whenever rations with zeolite are designed for ruminants.
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Introduction
One common approach of preventing periparturient hypocalcaemia in dairy cows is to feed a Ca restricted diet before parturition (Boda and Cole, 1954) . The effect on
Ca homeostasis results in an enhanced secretion of parathyroid hormone (PTH). By stimulating bone resorption (Goff et al., 1991) as well as the production of 1,25-dihydroxycholecalciferol (1,25-(OH)2D) (Hoenderop et al., 2005) , the cow is prepared for the sudden increase in Ca demand at the onset of lactation.
However, the typical ration fed to dairy cows usually contains far more Ca than the recommended 20 g per day. Therefore, several studies aimed at the reduction of Ca availability by adding the synthetic sodium aluminosilicate zeolite A to bind dietary Ca have been performed. In several studies, it has been shown that zeolite A supplementation during late gestation stabilizes blood Ca concentrations around parturition (Thilsing-Hansen and Jorgensen 2001; Thilsing-Hansen et al., 2002; Pallesen et al., 2008; Grabherr et al., 2009 ).
However, additional effects of zeolite A on plasma P (Enemark et al., 2003; Pallesen et al., 2008) and Mg (Thilsing-Hansen et al., 2002; Grabherr et al., 2009 ) as well as on urinary pH and renal excretion of minerals (Thilsing-Hansen et al., 2002) were also reported. Thus, the impact of zeolite A on mineral homeostasis appears more complex than just reducing the availability of Ca in the ration. 
Materials and Methods

Animals and housing
Seventeen growing goats (Saanen type breed, 11 weeks of age, 11 males and 6 females) were randomly assigned to two experimental (6 animals) groups and one control group (5 animals), respectively. Each group included two female and three (control group) or four (experimental group) male animals, respectively. The goat kids were kept in groups on wood shavings without straw. Goats were fed individually in single boxes for accurate monitoring of intake. Body weight was determined every fourth day. After three weeks on the experimental diets, the animals were slaughtered and samples were collected.
Feeding
The animals were fed hay (2nd cut) and concentrate (2957 Combifloc, Meliofeed AG, Herzogenbuchsee, Switzerland) according to feeding recommendations of the Swiss National Agriculture Research Institute in Posieux (Arrigo et al., 1999) . For the first two weeks of the trial, each animal received 560 g hay and 200 g concentrate per day, divided into two feedings. From day 13 of the experiment until the end of the observation period, the amount of hay was increased to 660 g per day. An hour after each feeding, the refusals were weighed to calculate daily intake. Nutrient content of hay and concentrate (Table 1) were analyzed by proximate analysis (Naumann and Bassler, 1997) or calculated from literature values and manufacturer´s data (Arrigo et al., 1999) .
Zeolite A (ZP 4A) (sodium aluminosilicate, chemical formula Na x [(AlO2) x (SiO2)y]zH2O; Silkem Vertriebs AG, Zug, Switzerland) was added to the concentrate fed to the goats of the two treatment groups at a dosage of either 1.2 g/kg BW (Z1.2) or 1.6 g/kg BW (Z1.6), respectively.
Collection of samples
Blood samples (10 mL) were collected in the morning before feeding on d 0, 2, 4, 7, 10, 13, 16, 19 and 21 from the vena jugularis externa using a vacutainer system (5 mL, without additives; Greiner Bio-One GmbH, St.Gallen, Switzerland). After centrifugation at room temperature (1,500 × g, 20 min), aliquots of serum were stored at -20°C and -80°C, respectively. 
Analysis of serum and urine samples
Analysis of Ca, P, Mg and Creatinine. Ca, P, Mg and Creatinine (Creat)
concentrations in serum and urine were determined by well-established colorimetric tests using an autoanalyzer (Cobas Mira Roche autoanalyzer, F. Hoffmann-La Roche Ltd., Basel, Switzerland). Commercial kits based on o-cresolphthalein complexone for Ca, ammonium molybdate for P, xylidyl blue for Mg and picric acid for Creat (Diatools, Villmergen, Switzerland) were used. The intra-and interassay CVs were 0.62% to 1.45% and 1.66% to 2.70% for Ca, 0.86% to 1.61% and 1.07% to 2.22% for P, 0.83% to 0.92% and 1.09% to 1.43% for Mg and 0.83% to 1.3% and 0.85% to 3.63% for Crea.
Analysis of 1,25-(OH)2D and 25-hydroxycholecalciferol.
Commercial RIA kits (Immunodiagnostic systems GmbH, Frankfurt am Main, Germany) were used for analyzing serum concentrations of 1,25-(OH)2D and 25-hydroxycholecalciferol (25-OHD). The intra-and interassay CVs were 9.1% to 10.8% and 9.6% to 13.6% for 1,25-(OH)2D and 5.0% to 6.1% and 7.3% to 8.2% for 25-OHD.
Analysis of Osteocalcin and Serum CrossLaps. Osteocalcin (OC) concentrations
in serum were measured using a commercial EIA kit (Quidel Corporation, San Diego, USA) and Serum CrossLaps (SCL) by a commercial ELISA kit (Immunodiagnostic systems GmbH, Frankfurt am Main, Germany). The intra-and interassay CVs were 4.8% to 10.0% and 4.8% to 9.8% for OC and 1.7% to 3.0% and 2.5% to 10.9% for SCL. The bone formation and resorption markers OC and SCL were validated for goats by Liesegang et al. (Liesegang et al., 2003) .
Ussing chamber technique
Flux rates of Ca in RU and DD were determined by Ussing chamber technique and were already described by Sidler-Lauff et al. (2010) . Uniderectional flux rates were measured (J ms : mucosal to serosal flux rates and J sm : serosal to mucosal flux rates) and net flux rates were calculated (J net = J ms -J sm ).
Quantitative RT-PCR
For quantification of RNA expression, isolation of total RNA and synthesis of cDNA were carried out using commercial kits according to the manufacturers´ protocols ( Custom made primers were validated by the manufacturing company. Assays were checked for appropriate efficiency (90-105%) using dilution series of cDNA.
Quantitative RT-PCR was carried out using a 7500 Fast Real-Time PCR System (Applied Biosystems) with a standard protocol (95°C, 20 s; 45 cycles of 95°C, 3 s and 60°C, 30 s). For relative quantification the ddCT method was used. Values of CaBP9k and VDR were normalized against the house keeping gene beta-actin.
Quantitative RT-PCR of the housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH), the transient receptor potential vanilloid type 5/6 channels (TRPV5/6), calbindin-D28K (CaBP-28k), intestinal plasma calcium ATPase (PMCA1b), renal Na/Ca exchanger (NCX) and renal 1α-hydroxylase was done as described for goat samples earlier (Wilkens et al., 2012 , Herm et al., 2015 . Copy numbers of TRPV5/6, CaBP-28k, PMCA1b and NCX were calculated using standard curves and normalized to the expression of the house keeping gene GAPDH.
Western blot analysis
Protein extraction and Western blot analysis of VDR and CaBP-28k were carried out as described by Kovács et al. (2015) . As primary antibody, monoclonal antibodies against VDR (Abcam, Cambridge, UK, diluted 1:200 in TBST) or CaBP-28k (Swant, Bellinzona, Switzerland, diluted 1:500 in TBST), respectively, were used. As secondary antibody a horseradish peroxidase (HRP)-conjugated goat anti-rat antibody (Sigma-Aldrich, St. Louis, USA, diluted 1:10,000 in TBST/2.5% fat-free milk)
was used for detection of VDR. In case of CaBP-28k a peroxidase-conjugated antimouse antibody (Sigma-Aldrich, St. Louis, USA, diluted 1:20,000 in TBST/2.5% fatfree milk) was applied. Detection was achieved using enhanced chemiluminescence (Super Signal West Femto Maximum Sensitivity Substrate; Socochim, Lausanne, Switzerland) and a ChemiDoc system (Bio Rad, Cressier, Switzerland). The protein expression of VDR and CaBP-28k were normalized to the amount of GAPDH determined by means of a monoclonal antibody against GAPDH (Sigma-Aldrich, St.
Louis, USA, diluted 1:30,000 in TBST) and a peroxidase-conjugated anti-mouse antibody (Sigma-Aldrich, St. Louis, USA, diluted 1:40,000 in TBST/2.5% fat-free milk). Quantities were calculated as the ratio of VDR or CaPB-28k to GAPDH.
Protein extraction and Western blot analysis of TRPV5/6, PMCA and CaBP-9k were done as already described before for sheep and goat tissues (Schröder et al., 2001; Wilkens et al., 2011; Wilkens et al., 2012; Herm et al., 2015) .
Peripheral quantitative computed tomographie (pQCT)
Bone mineral density (BMD) and bone mineral content (BMC) were measured by peripheral quantitative computed tomography on d 0, 7 and 13 with Stratec XCT 960A (Stratec Medizintechnik GmbH, Pforzheim, Germany). The goats were placed in a lateral position on an examination table and the left metatarsus was held in the CT tube by a plexiglas tube. The length was defined as the distance between dewclaw and calcaneus. The densitometry was taken at two positions, at 10% and 50% of the overall length. After slaughtering, the left metatarsus was removed, freed of soft tissue and bone density was measured at the 50% and 10% positions of the total length.
Statistical analysis
All results are presented as mean ± SEM. To test the difference of time-dependent patterns of plasma parameters and renal excretion analysis of variance for repeated measurements (RM ANOVA) followed by Bonferroni post-test were conducted.
Comparison of results of Ca flux rates, RNA and protein expression was carried out by one-way ANOVA followed by post-testing for linear trends.
Level of significance was set at a value of P < 0.05. All tests were performed by GraphPad Prism Version 6.00 (GraphPad Software, San Diego, California, USA).
Results
Feed intake and live weight changes
Mean intake of nutrients and minerals is presented in Table 1 . The average body weight of the growing goats was 19.2 ± 2.5 kg at the beginning of the trial, increased continuously during the trial, and was 21.1 ± 2.5 kg at the end (Table 2) .
Serum concentrations of minerals
Serum concentrations of macrominerals are depicted in Fig. 1 .
During the entire observation period, mean serum Ca concentrations of all groups remained within the physiological range for adult goats (2.2 mM -2.7 mM [Tschuor et al., 2008] ). Slight alterations over time could be observed (P = 0.0018).
Serum P concentrations of both treatment groups were significantly altered in a dosedependent manner (P < 0.0001). Beginning with day 4, serum concentrations of P determined for group Z1.6 decreased below the reference value of 1.2 mM (Tschuor et al., 2008) .
A significant decline due to the supplementation with zeolite could also been shown for serum concentrations of Mg (effect of time: P < 0.0001, effect of treatment: P = 0.0034).
Urinary pH and renal excretion of Ca, P and Mg
Urinary pH ranged between 8.271 and 8.443 and was not affected by treatment.
Ratios of respective minerals normalized to Creat are presented in Fig. 2 . While Ca excretion was slightly increased by zeolite supplementation (P = 0.0195), renal excretion of P was significantly reduced in both treatment groups (P = 0.0177).
Serum concentrations of vitamin D metabolites
While circulating concentrations of 25-OHD were not significantly affected by the treatment, serum concentrations of 1,25-(OH)2D decreased in group Z1.6 during the observation period (Fig. 3) (effect of time: P = 0.0007, effect of treatment: P = 0.0047). Z1.6 = supplemented with 1.6 g zeolite/kg BW (n = 6)
Analysis of bone parameters: Serum concentrations of SCL and OC; BMD, BMC
During the observation period, SCL and OC showed opposing trends resulting in a significant influence of the treatment on the ratio of bone formation to bone resorption (Fig. 4) (P = 0.0498). No differences in BMD or BMC were observed (Table 3) 
Ussing chamber experiments
In RU, J ms of Ca exceeded J sm . The resulting positive J net indicating net absorption was not significantly influenced by the experimental diets. Mean values amounted to 1.9 ± 0.2 nmol/(cm2·h) in the control group, 7.3 ± 2.6 nmol/(cm2·h) in group Z1.2, and 3.9 ± 1.4 nmol/(cm2·h) in group Z1.6.
In DD, J sm exceeded J ms , resulting in a negative J net indicating a net secretion of Ca that was not affected by the diet. Mean values amounted to -8.7 ± 2.1 nmol/(cm2 h) in the control group, -12.4 ± 3.2 nmol/(cm2 h) in group Z1.2 and -9.4 ± 2.2 nmol/(cm2 h) in group Z1.6. goats belonging to the control group (Control, n = 5) or supplemented with zeolite in a dosage of 1.2 g/kg BW (Z1.2, n = 6) or 1.6 g/kg BW (Z1.6, n = 6). Data are given as means ± SEM. Analysis of variance for repeated measurements revealed an effect of time on calcium (P < 0.01) and effects of time, supplementation and an interaction of both factors on phosphate (P < 0.001, P < 0.001, P < 0.001) and magnesium (P < 0.001, P < 0.01, P < 0.001). Differences revealed for the respective time point by Bonferroni post-test between control and Z1.2 or between control and Z1.6 are indicated by * (Z.1.2) and # (Z1.6). Z1.2 = supplemented with 1.2 g zeolite/kg BW (n = 6) 4 Z1.6 = supplemented with 1.6 g zeolite/kg BW (n = 6)
For total medial and cortical content, ANOVA followed by Tukey´post-test revealed a significant effect of the experimental group (Control vs. Z1.2: P < 0.05), while an effect of time was revealed for cortical density (day 0 vs. day 21: P < 0.01). interaction of time and the supplementation on CrossLaps (P < 0.001, P < 0.05) and on osteocalcin (P < 0.001, P < 0.05), while effects of time, the supplementation and an interaction of both factors (P < 0.001, P < 0.05, P < 0.01) could be shown for the ratio of the both bone markers. Differences revealed for the respective time point by Bonferroni post-test between control and Z1.2 or between control and Z1.6 are indicated by * (Z.1.2) and # (Z1.6).
Expression of VDR, 1α-hydroxylase and structures involved in transcellular Ca transport
Data on duodenal expression are given in Fig. 5 . No effects could be found for RNA expression of VDR and PMCA, while RNA expression of TRPV6 and CaBP-9k
showed a trend for reduction with the zeolite supplementation (P = 0.0975, P = 0.0443). Protein expression decreased by the treatment for CaBP-9k (P = 0.657) and showed no differences for VDR or PMCA. Examples of Western blots are given in Fig. 6 .
In renal tissues, RNA expression of TRPV5, CaBP-28k and NCX1 as well as protein expression of CaBP-28k were increased by the treatment (P = 0.0692, P = 0.0455, P = 0.0029, P=0.0004), while expression of VDR and 1α-hydroxylase was not altered (Fig. 7) . 
Discussion
Goat kids of group Z1.6 showed a slight increase in mean serum Ca concentrations compared with the control group. However, neither an elevation of 1,25-(OH)2D3 nor an elevation of active gastrointestinal absorption was detected. This confirms hypothesis 3, which assumed a stimulated Ca mobilization, but rejects hypothesis 2, which assumed an involvement of 1,25-(OH)2D3.
In an in-vitro study, Thilsing et al. (2006) showed that zeolite might bind Ca in the rumen, but could release it again in the abomasum. Perhaps the capacity of zeolite to bind Ca in the rumen, especially in combination with the above mentioned release, might be too small to have a relevant effect on the Ca homeostasis of the goats. In fact, the binding capacity of zeolite to P seems to be more effective. In the acidic pH in the abomasum, zeolite A breaks down and silicic acid, aluminium and amorphous aluminium silicates are set free (Cook et al., 1982) . Aluminium ions are able to form tight complexes with P (Allen, 1984) . These complexes remain insoluble and therefore indigestible throughout the rest of the gastrointestinal tract, while Ca is released in the abomasum and available in the intestine. This is in accordance to several in vivo experiments, where a significant decrease in serum P concentrations during zeolite administration has been reported (Enemark et al., 2003; Pallesen et al., 2008) . In humans, several products like calcium acetate, lanthanum carbonate or sevelamer carbonate are known to bind phosphate and are used as therapeutics, for example in chronic kidney diseases. Phosphorus binders significantly lower serum und urine P concentrations during their application (Block et al. 2012 ).
Low concentrations of P are discussed to be responsible for the elevation of mean Ca concentrations in the blood. A significant reduction in serum P was observed in both treatment groups. In several studies with sheep (Maunder et al., 1986; Scott et al., 1997) , goats (Schröder et al., 1995) and cattle (Kichura et al., 1982; Barton et al., 1987) it has been reported that diets low in P lead to an increase in Ca concentrations in blood. In contrast to monogastric animals, this increase happens without any change in circulating concentrations of 1,25-(OH)2D3 (Schröder et al., 1995; Scott et al., 1997) . There is evidence for increased binding affinity of intestinal VDR receptors to 1,25-(OH)2D3 in P-depleted lactating goats (Schröder et al., 1990) .
For growing goats, a comparable impact could not be shown (Schröder et al., 1995) .
In addition, the effect on intestinal VDR seems unlikely because neither elevated active Ca absorption in the treatment groups determined by Ussing chamber technique nor changes in intestinal RNA and protein expression of Ca transporters could be observed.
In fact, in ruminants reduced P intake may cause a rise in bone resorption without involvement of 1,25-(OH)2D3 (Scott et al., 1997) . The exact mechanisms mediating this phenomenon are still unknown, but a lack of P for creating hydroxyapatite crystals is suggested. The changes in the ratio of SCL to OC in the treatment groups indicate elevated bone resorption together with reduced bone formation in these groups. Osteocalcin is known to decrease physiologically with age (Corlett et al., 1990) . However, because of stable values in the control group, increased maturity does not seem to be the reason for the decreased OC concentrations during that time in the present study. Bone resorption was uncoupled from bone formation and overbalanced in the treatment groups. However, there were no differences in BMD and BMC. Possibly the length of the trial was too short for apparent changes in bone structure.
In addition to low P concentrations, reduced dietary Mg intake is also known to alter bone structure. In both treatment groups, a significant reduction of Mg concentrations in serum over time was evident. In accordance with these findings, Enemark et al. (2003) presented significantly lower Mg concentrations in serum of treated dry cows compared with control group. Furthermore Thilsing et al. (2006) showed in an in vitro study, a zeolite-induced reduction of Mg in supernatants of rumen fluid. On the contrary, Pallesen et al. (2008) observed no differences of serum Mg concentrations during zeolite application.
Rats fed diets restricted in Mg showed decreased 1,25-(OH)2D3 concentrations, decreased bone volume, decreased trabecular thickness and increased numbers of osteoclasts compared to control animals (Rude, 2008) . In the present study reduced 1,25-(OH)2D3 concentrations in group Z1.6 and a reduced ratio of bone formation to bone resorption were evident. The effect of zeolite A on bone remodeling could be a combination of both pathways, reduced P and Mg intake.
The decrease of 1,25-(OH)2D3 caused by low dietary Mg intake is explainable by a reduction of secretion and action of PTH through altered phosphoinositol activity and decreased adenylate cyclase activity (Rude, 2008) . Furthermore, there is evidence for Mg-dependency of the renal 1α-hydroxylase activity (CYP27B1) (Rude, 2008 ). An effect on enzyme activity rather than on its expression would be in line with our results on CYP27B1 expression. Another explanation for reduced 1,25-(OH)2D3
contents could be a reduction of circulating PTH through low concentrations of P. In rats, dietary induced P deficiency causes a fall of serum PTH concentrations (Rader et al., 1979) . Because no suitable assay for caprine PTH is available, the determination of serum PTH concentrations in the present study was not possible.
Active Ca absorption in the GIT and its renal reabsorption are mediated by at least three steps. Driven by an electrochemical gradient Ca enters the cell via selective, apically located Ca channels, the TRPV type 6 mainly in intestines and type 5 mainly in kidneys (Hoenderop et al., 1999; Peng et al., 1999) . It is then translocated to the basolateral membrane bound to Ca binding proteins: CaBP-9k in intestines, CaBP28k in the kidney (Wasserman et al., 1966; Kallfelz et al., 1967) . Extrusion of Ca out of intestinal epithelial cells is mediated mainly by an energy dependent Ca efflux pump, the PMCA1b (Ghijsen et al., 1982) . In the kidney, extrusion of Ca is predominantly conducted by NCX1 (Loffing and Kaissling, 2003) .
Ussing chamber experiments in absence of any electrochemical gradient revealed active Ca absorption in the rumen and a secretion of Ca in the duodenum. This is in accordance with results from former studies in which active Ca absorption in the duodenum occurred only in goats kept on dietary Ca restriction (Wilkens et al., 2012) .
In the present study, dietary Ca supply was probably high enough to meet the daily requirements by passive diffusion. The relatively high Ca intake might also explain why the reduction in expression of TRPV6 and CaBP-9k induced by lower 1,25-(OH)2D3 serum concentration did not negatively affect Ca balance.
Results of renal Ca resorption are contradictory in the present study. Because of significantly higher concentrations of the Ca transport protein CaBP-28k and higher RNA expression of TRPV5 and NCX1, an increased Ca reabsorption and therefore a reduced excretion in urine might be expected. However, a tendency to a higher Ca excretion in both treatment groups was evident. In an earlier study with zeolite A on dairy cows, higher Ca excretion in urine was also obvious (Grabherr et al., 2009) . It was shown for monogastric animals (Coburn and Massry, 1970 ) that low concentrations of P are able to cause increased Ca excretion in urine. One possible explanation may be a decreased reabsorption of Ca in kidneys through decreased activity of the parathyroid gland, because low concentrations of P may decrease the concentrations of circulating PTH. However, Herm et al. (2015) were able to show that modulations of renal Ca transport proteins in ruminants differ substantially from results reported for monogastric animals. During dietary Ca restriction (0.26% Ca for sheep, 0.22% Ca for goats) the animals showed no changes or even a downregulation of the Ca transport proteins TRPV5, CaBP-28k and NCX (Herm et al. 2015) . Against the background of this finding, an influence of physiological concentrations of 1,25-(OH)2D3 on Ca reabsorption in the kidney of small ruminants seems unlikely. The reason for the higher RNA expression of CaBP-28k and NCX in the kidneys of group Z1.6 is unclear. It could be speculated that increased Ca filtration due to greater Ca plasma concentration would lead to increased Ca concentrations in the tubular fluid reaching the distal tubules. The Ca concentration in the tubular fluid might be involved in regulating RNA expression of CaBP-28k and NCX. This hypothesis is supported by the existence of so-called calcium responsive elements in the promoter region of the CaBP-28k gene in mice (Arnold and Heintz, 1997) . However, in the present study, the increase of RNA expression of CaBP-28k
and NCX in kidneys was not as high as it is would be needed to reduce Ca excretion significantly.
P excretion in urine of treatment groups was reduced during the present trial. This might be explained by an adaptation of the kidneys to the low serum concentrations of P. This increases renal P reabsorption and therefore decreases urinary P excretion, which is in accordance with other studies on zeolite (Enemark et al., 2003; Grabherr et al., 2009 ).
In the present study, a dose-dependent effect of zeolite was apparent. Serum Mg concentrations were only significantly different in group Z1.6 compared to the control group, while serum concentrations of P declined in a dose-dependent manner.
Furthermore, alterations of intestinal and renal RNA and protein expression of Ca transporting structures showed linear trends with dosage.
Whether Ca availability in the diet is reduced significantly by zeolite A has not been answered until now. However, with the findings from the present study reduced P availability is more obvious. In contrast to our expectations, an elevation of 1,25-(OH)2D3 in treatment groups was not shown during application of zeolite A.
Therefore, our hypothesis 2 has to be rejected. Neither an increased active Ca absorption in gastrointestinal tract, nor a reduced Ca excretion in kidney was shown.
However, bone mobilization outweighed bone formation; therefore our hypothesis 3 is partially verified. With the findings of this study new hypotheses can be formulated:
(1): Zeolite A binds dietary P in abomasum and therefore reduces blood P concentrations. (2) Reduced blood P concentrations alter bone remodeling rate what (3) increases Ca concentrations in blood. However, whenever rations with zeolite are designed for ruminants, the effects on 1,25-(OH)2D3, bone metabolism and serum concentrations of P and Mg, which were shown in the present study, should be considered.
